Transseptal access through atrial flow regulator device during ventricular tachycardia ablation.

Muhammet Dural Hikmet Yorgun Uğur CanpolatErgun Baris KayaKudret Aytemir

Published in: Pacing and clinical electrophysiology : PACE (2020)

Novel interventional therapies for heart failure patients are emerging like atrial flow regulator (AFR). Our case showed that endocardial ventricular tachycardia (VT) ablation could be performed safely by passing through the AFR device lumen without additional transseptal puncture in these patients.

Keyphrases

ejection fraction
catheter ablation
end stage renal disease
atrial fibrillation
transcription factor
newly diagnosed
chronic kidney disease
left atrial
ultrasound guided
peritoneal dialysis
radiofrequency ablation
left ventricular